Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism.
Veneri FA, Prada V, Mastrangelo R, Ferri C, Nobbio L, Passalacqua M, Milanesi M, Bianchi F, Del Carro U, Vallat JM, Duong P, Svaren J, Schenone A, Grandis M, D'Antonio M. Veneri FA, et al. Among authors: mastrangelo r. Hum Mol Genet. 2022 Dec 16;31(24):4255-4274. doi: 10.1093/hmg/ddac170. Hum Mol Genet. 2022. PMID: 35908287 Free PMC article.
Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice.
Bai Y, Treins C, Volpi VG, Scapin C, Ferri C, Mastrangelo R, Touvier T, Florio F, Bianchi F, Del Carro U, Baas FF, Wang D, Miniou P, Guedat P, Shy ME, D'Antonio M. Bai Y, et al. Among authors: mastrangelo r. Mol Neurobiol. 2022 Jul;59(7):4159-4178. doi: 10.1007/s12035-022-02838-y. Epub 2022 Apr 30. Mol Neurobiol. 2022. PMID: 35501630 Free PMC article.
Neuroactive steroids and diabetic complications in the nervous system.
Giatti S, Mastrangelo R, D'Antonio M, Pesaresi M, Romano S, Diviccaro S, Caruso D, Mitro N, Melcangi RC. Giatti S, et al. Among authors: mastrangelo r. Front Neuroendocrinol. 2018 Jan;48:58-69. doi: 10.1016/j.yfrne.2017.07.006. Epub 2017 Jul 21. Front Neuroendocrinol. 2018. PMID: 28739507 Review.
Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B.
Touvier T, Veneri FA, Claessens A, Ferri C, Mastrangelo R, Sorgiati N, Bianchi F, Valenzano S, Del Carro U, Rivellini C, Duong P, Shy ME, Kelly JW, Svaren J, Wiseman RL, D'Antonio M. Touvier T, et al. Among authors: mastrangelo r. bioRxiv [Preprint]. 2024 Feb 2:2024.01.31.577760. doi: 10.1101/2024.01.31.577760. bioRxiv. 2024. PMID: 38352425 Free PMC article. Preprint.
95 results